Correlation Between Monte Rosa and Tcr2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Tcr2 Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Tcr2 Therapeutics.
Diversification Opportunities for Monte Rosa and Tcr2 Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Monte and Tcr2 is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Tcr2 Therapeutics go up and down completely randomly.
Pair Corralation between Monte Rosa and Tcr2 Therapeutics
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 2.38 times more return on investment than Tcr2 Therapeutics. However, Monte Rosa is 2.38 times more volatile than Tcr2 Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Tcr2 Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 840.00 in Monte Rosa Therapeutics on August 24, 2024 and sell it today you would earn a total of 9.00 from holding Monte Rosa Therapeutics or generate 1.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 10.36% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Tcr2 Therapeutics
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Monte Rosa and Tcr2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Tcr2 Therapeutics
The main advantage of trading using opposite Monte Rosa and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |